Trial
NCT03692221
Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Hospitals Cleveland Medical Center
Collaborators
—
Condition
Disc Degeneration
Intervention
MSC Treatment group 1 (low dose)
Why stopped
Stalled due to Covid
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-05